SciELO - Scientific Electronic Library Online

 
vol.80 número1Dental biomaterials: challenges in the translation from lab to patientThe use of cone beam computed tomography in establishing the etiology of an impacted tooth índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

    Links relacionados

    • En proceso de indezaciónCitado por Google
    • En proceso de indezaciónSimilares en Google

    Compartir


    South African Dental Journal

    versión On-line ISSN 0375-1562versión impresa ISSN 0011-8516

    Resumen

    FOURIE, J; LAUBSCHER, D  y  SIMELANE, T. Methotrexate-induced oral mucositis in patients with rheumatoid arthritis: A case series and literature review. S. Afr. dent. j. [online]. 2025, vol.80, n.1, pp.33-41. ISSN 0375-1562.  https://doi.org/10.17159/sadj.v80i01.20071.

    INTRODUCTION: Methotrexate is used as both an antineoplastic drug and disease-modifying anti-rheumatic drug. In both cases, methotrexate use may result in oral mucositis. Dentists are likely to manage patients with rheumatoid arthritis and should consider this adverse drug event when mouth ulcers are observed. AIMS AND OBJECTIVES: This study aims to report on five patients with rheumatoid arthritis who presented with methotrexate-induced oral mucositis (MIOM) and to perform a literature review of the condition. DESIGN/METHODS: The clinical history, oral mucosal features and results of special investigations of five patients who presented to the Oral Medicine Clinic with MIOM were recorded. Upon identification of methotrexate use as the cause of oral ulceration, the patients were managed collaboratively with their respective physicians. RESULTS: These cases demonstrate that dentists should recognise that chemotherapy-induced oral mucositis may also be seen among patients with rheumatoid arthritis, and not necessarily only within the traditional context of cancer treatment. Dentists should consider the possibility of drug reactions and interactions that may result in oral ulcers. CONCLUSIONS: Dentists play a pivotal role in the diagnosis and treatment of mouth ulcers. Careful history taking and suspicion of adverse drug events described here may facilitate a clinical diagnosis, which can be further supported through special investigations. Collaboration with the treating medical clinician is imperative in the management of a patient who presents with MIOM, as treatment modification is required.

    Palabras clave : Methotrexate; oral ulceration; mucositis; DMARD; pancytopenia; rheumatoid arthritis.

            · texto en Inglés     · Inglés ( pdf )